Cargando…
Targeting Glioblastoma-Associated Macrophages for Photodynamic Therapy Using AGuIX(®)-Design Nanoparticles
Glioblastoma (GBM) is the most difficult brain cancer to treat, and photodynamic therapy (PDT) is emerging as a complementary approach to improve tumor eradication. Neuropilin-1 (NRP-1) protein expression plays a critical role in GBM progression and immune response. Moreover, various clinical databa...
Autores principales: | Lerouge, Lucie, Gries, Mickaël, Chateau, Alicia, Daouk, Joël, Lux, François, Rocchi, Paul, Cedervall, Jessica, Olsson, Anna-Karin, Tillement, Olivier, Frochot, Céline, Acherar, Samir, Thomas, Noémie, Barberi-Heyob, Muriel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10057379/ https://www.ncbi.nlm.nih.gov/pubmed/36986856 http://dx.doi.org/10.3390/pharmaceutics15030997 |
Ejemplares similares
-
Multiscale Selectivity and in vivo Biodistribution of NRP-1-Targeted Theranostic AGuIX Nanoparticles for PDT of Glioblastoma
por: Gries, Mickaël, et al.
Publicado: (2020) -
Ultrasmall AGuIX theranostic nanoparticles for vascular-targeted interstitial photodynamic therapy of glioblastoma
por: Thomas, Eloïse, et al.
Publicado: (2017) -
Terbium-Based AGuIX-Design Nanoparticle to Mediate X-ray-Induced Photodynamic Therapy
por: Daouk, Joël, et al.
Publicado: (2021) -
Functionalization of theranostic AGuIX® nanoparticles for PET/MRI/optical imaging
por: Thakare, Vivek, et al.
Publicado: (2019) -
AGuIX nanoparticles as a promising platform for image-guided radiation therapy
por: Detappe, Alexandre, et al.
Publicado: (2015)